The cost effectiveness of lenvatinib versus atezolizumab and bevacizumab or sorafenib in patients with unresectable hepatocellular carcinoma (uHCC) in Canada.

被引：1
|
作者：
Trueman, David
Liu, Yifeng
Geadah, Marc
Hon, Nicholas
Sabapathy, Suthakar
Kamboj, Laveena
Li, Huimin
Lucero, Melanie
Meier, Genevieve
机构：
[1] Source Hlth Econ, London, England
[2] PIVINA Consulting Inc, Mississauga, ON, Canada
[3] Eisai Ltd, Mississauga, ON, Canada
[4] HAS Consulting Inc, Derwood, MD USA
[5] Eisai Inc, Woodcliff Lake, NJ USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2021年 / 39卷 / 15期
关键词：
D O I：
10.1200/JCO.2021.39.15_suppl.4098
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4098
引用
收藏
页数：2
相关论文
共 50 条
  • [1] The comparative efficacy of atezolizumab and bevacizumab versus lenvatinib in patients with unresectable hepatocellular carcinoma (uHCC).
    Trueman, David
    Liu, Yifeng
    Lucero, Melanie
    Meier, Genevieve
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [2] Cost-effectiveness analysis of lenvatinib treatment for patients with unresectable hepatocellular carcinoma (uHCC) compared with sorafenib in Japan
    Masahiro Kobayashi
    Masatoshi Kudo
    Namiki Izumi
    Shuichi Kaneko
    Mie Azuma
    Ronda Copher
    Genevieve Meier
    Janice Pan
    Mika Ishii
    Shunya Ikeda
    [J]. Journal of Gastroenterology, 2019, 54 : 558 - 570
  • [3] Cost-effectiveness analysis of lenvatinib treatment for patients with unresectable hepatocellular carcinoma (uHCC) compared with sorafenib in Japan
    Kobayashi, Masahiro
    Kudo, Masatoshi
    Izumi, Namiki
    Kaneko, Shuichi
    Azuma, Mie
    Copher, Ronda
    Meier, Genevieve
    Pan, Janice
    Ishii, Mika
    Ikeda, Shunya
    [J]. JOURNAL OF GASTROENTEROLOGY, 2019, 54 (06) : 558 - 570
  • [4] Lenvatinib versus sorafenib for unresectable hepatocellular carcinoma: a cost-effectiveness analysis
    Cai, Hongfu
    Zhang, Longfeng
    Li, Na
    Zheng, Bin
    Liu, Maobai
    [J]. JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH, 2020, 9 (08) : 553 - 562
  • [5] Cost-effectiveness of Atezolizumab Plus Bevacizumab vs Sorafenib for Patients With Unresectable or Metastatic Hepatocellular Carcinoma
    Zhang, Xin
    Wang, Jingjing
    Shi, Juanjuan
    Jia, Xiaoli
    Dang, Shuangsuo
    Wang, Wenjun
    [J]. JAMA NETWORK OPEN, 2021, 4 (04)
  • [6] Effectiveness of Lenvatinib Versus Sorafenib for Unresectable Hepatocellular Carcinoma in Patients with Hepatic Decompensation
    Park, Min Kyung
    Lee, Yun Bin
    Moon, Hyemi
    Choi, Na Ryung
    Kim, Minseok Albert
    Jang, Heejoon
    Nam, Joon Yeul
    Cho, Eun Ju
    Lee, Jeong-Hoon
    Yu, Su Jong
    Kim, Yoon Jun
    Yoon, Jung-Hwan
    [J]. DIGESTIVE DISEASES AND SCIENCES, 2022, 67 (10) : 4939 - 4949
  • [7] EFFECTIVENESS OF LENVATINIB VERSUS SORAFENIB FOR UNRESECTABLE HEPATOCELLULAR CARCINOMA IN PATIENTS WITH HEPATIC DECOMPENSATION
    Park, Min Kyung
    Lee, Yun Bin
    Moon, Hyemi
    Choi, Na Ryung
    Kim, Minseok Albert
    Nam, Joon Yeul
    Cho, Eun Ju
    Lee, Jeong-Hoon
    Yu, Su Jong
    Kim, Yoon Jun
    Yoon, Jung-Hwan
    [J]. HEPATOLOGY, 2021, 74 : 637A - 637A
  • [8] Effectiveness of Lenvatinib Versus Sorafenib for Unresectable Hepatocellular Carcinoma in Patients with Hepatic Decompensation
    Min Kyung Park
    Yun Bin Lee
    Hyemi Moon
    Na Ryung Choi
    Minseok Albert Kim
    Heejoon Jang
    Joon Yeul Nam
    Eun Ju Cho
    Jeong-Hoon Lee
    Su Jong Yu
    Yoon Jun Kim
    Jung-Hwan Yoon
    [J]. Digestive Diseases and Sciences, 2022, 67 : 4939 - 4949
  • [9] Atezolizumab plus bevacizumab versus lenvatinib or sorafenib in non-viral unresectable hepatocellular carcinoma: An international study
    Rimini, M.
    Rimassa, L.
    Kudo, M.
    Shigeo, S.
    Toshifumi, T.
    Suda, G.
    Yoo, C.
    Cheon, J.
    Lonardi, S.
    Scartozzi, M.
    Tamburini, E.
    Masi, G.
    Cascinu, S.
    Casadei-Gardini, A.
    [J]. ANNALS OF ONCOLOGY, 2022, 33 : S362 - S363
  • [10] Survival outcomes from Atezolizumab plus Bevacizumab versus Lenvatinib versus Sorafenib in Child Pugh B unresectable hepatocellular carcinoma patients
    Rimini, Margherita
    Persano, Mara
    Tada, Toshifumi
    Suda, Goki
    Shigeo, Shimose
    Kudo, Masatoshi
    Cheon, Jaekyung
    Finkelmeier, Fabian
    Lim, Ho Yeong
    Presa, Jose
    Lonardi, Sara
    Piscaglia, Fabio
    Chon, Hong Jae
    Masi, Gianluca
    Scartozzi, Mario
    Cascinu, Stefano
    Casadei-Gardini, Andrea
    [J]. JOURNAL OF HEPATOLOGY, 2023, 78 : S592 - S592
12345